Marie Bex

Turnhout, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

ACTH-secreting atypical carcinoid lung tumour expanding the Lynch syndrome spectrum.

ACTH-secreting atypical carcinoid lung tumour expanding the Lynch syndrome spectrum.

Journal: Journal of medical genetics

Published: May 23, 2025

Correction to: Osilodrostat improves blood pressure and glycemic control in patients with Cushing's disease: a pooled analysis of LINC 3 and LINC 4 studies.

Correction to: Osilodrostat improves blood pressure and glycemic control in patients with Cushing's disease: a pooled analysis of LINC 3 and LINC 4 studies.

Journal: Pituitary

Published: May 21, 2025

Osilodrostat improves blood pressure and glycemic control in patients with Cushing's disease: a pooled analysis of LINC 3 and LINC 4 studies.

Osilodrostat improves blood pressure and glycemic control in patients with Cushing's disease: a pooled analysis of LINC 3 and LINC 4 studies.

Journal: Pituitary

Published: December 12, 2024

Policy for transitioning childhood-onset growth hormone deficiency from pediatric to adult endocrine care in Belgium.

Policy for transitioning childhood-onset growth hormone deficiency from pediatric to adult endocrine care in Belgium.

Journal: Frontiers in endocrinology

Published: July 05, 2024

Fulminant ectopic Cushing's syndrome caused by metastatic small intestine neuroendocrine tumour - a case report and review of the literature.

Fulminant ectopic Cushing's syndrome caused by metastatic small intestine neuroendocrine tumour - a case report and review of the literature.

Journal: Acta gastro-enterologica Belgica

Published: March 03, 2024

Long-term efficacy and safety of osilodrostat in patients with Cushing's disease: results from the LINC 4 study extension.

Long-term efficacy and safety of osilodrostat in patients with Cushing's disease: results from the LINC 4 study extension.

Journal: Frontiers in endocrinology

Published: June 07, 2023

Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing's disease.

Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing's disease.

Journal: Frontiers in endocrinology

Published: February 14, 2023

[18F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [123I] MIBG in neural crest tumour patients.

[18F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [123I] MIBG in neural crest tumour patients.

Journal: European journal of nuclear medicine and molecular imaging

Published: August 09, 2022

Exploring stem cell biology in pituitary tumors and derived organoids.

Exploring stem cell biology in pituitary tumors and derived organoids.

Journal: Endocrine-related cancer

Published: March 17, 2022

Use of thyroid hormones in hypothyroid and euthyroid patients: a THESIS* survey of Belgian specialists *THESIS: treatment of hypothyroidism in Europe by specialists: an international survey.

Use of thyroid hormones in hypothyroid and euthyroid patients: a THESIS* survey of Belgian specialists *THESIS: treatment of hypothyroidism in Europe by specialists: an international survey.

Journal: Thyroid research

Published: January 16, 2022

Randomized Trial of Osilodrostat for the Treatment of Cushing Disease.

Randomized Trial of Osilodrostat for the Treatment of Cushing Disease.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 20, 2021

Endoscopic, Endonasal Transsphenoidal Surgery for Tumors of the Sellar and Suprasellar Region: A Monocentric Historical Cohort Study of 369 Patients.

Endoscopic, Endonasal Transsphenoidal Surgery for Tumors of the Sellar and Suprasellar Region: A Monocentric Historical Cohort Study of 369 Patients.

Journal: Frontiers in oncology

Published: December 18, 2020

Showing 1-12 of 22

Last Updated: 09/26/2026